Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
REVENUES $ 16,182,000 $ 25,079,000
COST OF REVENUES 10,080,000 15,297,000
GROSS PROFIT 6,102,000 9,782,000
OPERATING EXPENSE (INCOME)    
Selling, marketing and advertising 9,822,000 12,450,000
Engineering, technology and development 4,447,000 9,500,000
General and administrative 8,731,000 10,258,000
Contingent consideration (144,000) 1,075,000
Loss on intangible asset disposal 0 2,284,000
Impairment of intangible assets 0 7,052,000
Total operating expense 22,856,000 42,619,000
NET OPERATING LOSS (16,754,000) (32,837,000)
OTHER INCOME (EXPENSE)    
Gain on sale of intangible assets 183,000 0
Interest expense, including change in fair value of promissory notes carried at fair value (559,000) (50,000)
Loss on extinguishment of liability - contingent consideration (336,000) 0
Loss on exchange of preferred instruments 0 (681,000)
Change in fair value of warrant liability (1,115,000) (2,898,000)
Other (123,000) 27,000
Total other income 280,000 2,194,000
LOSS BEFORE (PROVISION FOR) BENEFIT FROM INCOME TAXES (16,474,000) (30,643,000)
(Provision for) benefit from income taxes (161,000) 313,000
NET LOSS $ (16,635,000) $ (30,330,000)
Net loss attributable to common stockholders - basic and diluted    
Basic and diluted loss per common share (1) (in dollars per share) [1] $ (2.35) $ (13.67)
Weighted-average number of common shares outstanding, basic and diluted (in shares) 8,940,304 2,799,044
[1] Refer to Note 2 for calculation of net loss attributable to common stockholders